4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000950170-24-030311
Chief Development Officer sold 29,768 shares at an average $3.31 ($98,605)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Machatha Stephen Chief Development Officer | 2024-03-11 | Sale | −18,231 | $3.41 | $62,102 | 255,032 | D |
| Machatha Stephen Chief Development Officer | 2024-03-12 | Sale | −11,537 | $3.16 | $36,503 | 243,495 | D |
| Derivatives | |||||||
| Machatha Stephen Chief Development Officer | 2024-03-09 | Grant or award · Stock Option (right to buy) | +405,450 | 405,450 | D | ||
| Open-market sales · 29,768 sh · avg $3.31 · $98,605 | |||||||
Loading xslF345X05/ownership.xml…